You are here: Home
Business
Investment
Update In The Shareholder Class Action Lawsuit Against China Shenghuo...
Update In The Shareholder Class Action Lawsuit Against China Shenghuo Pharmaceutical Holdings, Inc.
Update In The Shareholder Class Action Lawsuit Against China Shenghuo Pharmaceutical Holdings, Inc. (AMEX: KUN) Over Alleged Materially False And Misleasing Financial Statements - Deadline 10/20/2008
FOR IMMEDIATE RELEASE
(Free-Press-Release.com) October 16, 2008 --
There is a deadline coming up in the shareholder lawsuit against China Shenghuo Pharmaceutical Holdings, Inc. (AMEX: KUN) over allegedly false and misleading financial statements. The deadline will expire on October 20th, 2008.
If you purchased China Shenghuo Pharmaceutical Holdings, Inc. (AMEX: KUN) common stock between between July 23rd, 2007 through August 20th, 2008 you have certain rights and there are strict and short deadlines running (October 20th, 2008). You should immediately contact the Shareholders Foundation, Inc.!
Email: Mail@ShareholdersFoundation.com
or Call us TODAY!
Phone: +1-(858)-779-1554
A Shareholder has filed a securities class action lawsuit in the United States District Courts of Southern District of New York against China Shenghuo Pharmaceutical Holdings, Inc. (AMEX: KUN) on behalf of a all persons who purchased common stock of China Shenghuo Pharmaceutical Holdings, Inc. between July 23rd, 2007 through August 20th, 2008 over allegations that the company issued materially false and misleading financial statements in violation of the federal securities laws. According to the complaint on August 20th, 2008, the China Shenghuo Pharmaceutical Holdings, Inc. announced that its previously issued financial statements for the fiscal periods ended June 30th, September 30, and December 30th, 2007 and fiscal quarter ended March 31st, 2008, should no longer be relied upon and would be restated due to certain accounting errors, internal control issues and related matters. This adverse announcement shocked the market causing the Company’s stock to fall approximately 25%.
The complaint charges that China Shenghuo Pharmaceutical Holdings, Inc. and certain of its officers and directors violated Sections 10(b) and 20(a) of the 1934 Act by issuing materially false and misleading statements pertaining to CSP''''s business prospects and condition, and filing materially false financial statements with the SEC. The news from August 20th, 2008 that the Company''''s financial statements must be restated caused the Company''''s stock price to fall dramatically damaging investors.
If you purchased China Shenghuo Pharmaceutical Holdings, Inc. (AMEX: KUN) common stock between between July 23rd, 2007 through August 20th, 2008 you have certain rights and there are strict and short deadlines running (October 20th, 2008). You should immediately contact the Shareholders Foundation, Inc.!
Email: Mail@ShareholdersFoundation.com
or Call us TODAY!
Phone: +1-(858)-779-1554
or send us your information by mail /facsimile:
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423 -
92108 San Diego
Tel:+1-(858)-779-1554
Fax:+1-(858)-605-5739
Mail@ShareholdersFoundation.com
China Shenghuo Pharmaceutical class action lawsuit securities laws stock market stocks
Where: Athens,Greece
Industry: Business Services

Where: Mumbai,India
Industry: Business Services

Where: Athens,Greece
Industry: Business Services
Post your news to the World.See you news here immediately. It's easy and free!
Create free account or Login.



